Sentences with phrase «of pharmaceutical marketing»

A classic example of pharmaceutical marketing success made possible by veterinary greed.

It's intriguing that Twitter fired this up: I just hope that as much passion is put into promoting the right kinds of pharmaceutical marketing.

Every sector of the pharmaceutical market is represented under one roof, this year in Frankfurt.

Professor Hayday added: «This is very significant because antibodies make up one of the largest sectors of the pharmaceutical market, and one of the great quests in the pharmaceutical industry is to be able to routinely generate antibodies against human proteins implicated in diseases.

Not exact matches

Areas where positions are available: The world's sixth - largest pharmaceutical company has a number of open roles with sales and marketing, scientific positions, and jobs in its manufacturing and supply chain areas.

The guidelines rejected the possibility of full access to the EU's single market for crucial U.K. sectors such as finance and pharmaceuticals, stating there can be no «cherry picking» through participation based on a sector - by - sector approach.

Related: The Woman Who Brought «Female Viagra» to Market Is Stepping Down as CEO of Sprout Pharmaceuticals

You measure a country's ability to innovate using myriad factors, including registered trademarks, articles published in scientific journals and the size of its export market in fields like electronics or pharmaceuticals.

The biggest company in Canada by market cap on the TSX — an admittedly capricious metric — is now Valeant Pharmaceuticals, which surpassed the Royal Bank of Canada this week.

You may have heard that Valeant Pharmaceuticals didn't have the greatest 2016 (it shed 85 % of its market value over the course of the year).

State Attorney General Andy Beshear is bringing suit against Endo Pharmaceuticals, which makes the opioid Opana ER, for alleged fraudulent and deceptive marketing practices which have contributed to a rising tide of painkiller - related deaths in Kentucky.

Then the continuing wave of mergers and acquisitions created market - dominating behemoths of seemingly impossible size, in industries ranging from telecommunications and financial services to pharmaceuticals and the media.

According to the GAO report, 71 percent of all generic injectable cancer drugs sold in 2008 were produced by just three manufacturers, while 91 percent of the market share of injectable nutrients and supplements was held by just three pharmaceutical firms.

They appear to be looking into potentially anti-competitive business dealings that critics have leveled at this more than $ 20 billion niche market of the pharmaceutical industry, according to analysts and court filings reviewed by Kaiser Health News.

Illinois - based Marathon Pharmaceuticals will market deflazacort under the brand name Emflaza for a topline price of $ 89,000, 70 times higher than its price overseas, according to the Wall Street Journal.

Whitehead stepped down as CEO of Sprout Pharmaceuticals last December, as Valeant continued to bungle the libido - ramping pill's go - to - market strategy.

If the Canadian pharmaceuticals market was a high school, Domenic Pilla and Frank Scorpiniti would be the heads of rival cliques.

While this underlines the risks of investing in pre-revenue companies, the good news is biotech is strictly regulated by national pharmaceutical regulatory authorities in the US, Europe and China, which is one reason that biotech made sense for our market.

Why should we expect Mylan or any other pharmaceutical company to refrain from yanking up the price of lifesaving drugs as high as the market will bear?

Meanwhile, Congress has allowed Wall Street banks and pharmaceutical companies to accumulate the sort of vast market power that invites wrongdoing.

The company now controls nearly half of the market for insulin products — which are second only to oncology drugs as the fastest - growing category of pharmaceuticals.

Deals between pharmaceutical corporations and their generic drug competitors, which government officials say keep cheaper forms of medicine off the market, can sometimes be illegal and therefore can be challenged in court, the Supreme Court said Monday...

Major pharmaceuticals firms also engage in research and development, but tend to focus more on manufacturing and marketing an existing portfolio of drugs than the typical biotech firm.

The pharmaceutical industry is typically reluctant to talk about U.S. drug prices, generally the highest in the world due to a combination of market fragmentation and free market policies.

Assuming that the patented compound even makes it to the market, the statement that they only have a few years of exclusivity is definitely true — the market exclusivity for pharmaceuticals is almost always less than half of the patent exclusivity.

Valeant Pharmaceuticals International, Inc. (NYSE / TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorder, eye health, neurology and branded generics.

Dr. Hopfield is a former Partner of McKinsey & Company in its global pharmaceuticals and medical devices practice, where she led work in strategy, R&D management, and marketing across pharmaceutical, biotech, medical device and consumer industries.

With several drugs currently acting as significant drivers of growth, J&J's pharmaceutical segment looks well placed even as the company strives to maintain its market share in consumer healthcare and medical devices.

Following a number of real estate investment trusts, tech companies and pharmaceuticals, six companies are set to join the public markets this week.

The healthcare titan has hundreds of subsidiaries and core operations that dominate attractive market segments including consumer goods, medical devices, and pharmaceuticals.

However, the combination of smart capital management and a uniquely diverse product portfolio (spanning medical device sales, pharmaceuticals, and consumer products) has ensured that the healthcare titan's returns trounced the broader market over the long term.

Interviews with former Sprout employees, analysts, investors and doctors who helped bring the drug to market suggest how a series of missteps after the deal, along with turbulence from aggressive accounting practices, unusual business relationships and big egos, derailed one of the most intriguing new pharmaceuticals in a generation.

April 18 Kentucky's attorney general on Wednesday sued Johnson & Johnson, accusing the pharmaceutical manufacturer of devising a deceptive marketing scheme that mischaracterized the risk of opioid abuse and addiction.

What looks like a bubble at first glance can be viewed as a long - term strategy for funding drug development, one that involves private funds, pharmaceutical companies and the public markets, along with a good deal of risk — and, sometimes, high reward.

The iShares ETF is the largest covering the sector, tracking a set of biotechnology and pharmaceutical stocks that trade on the Nasdaq stock market.

Capital Markets Merger & Acquisitions: Biotech The slew of M&A deals in the pharmaceutical industry could leave some firms with a bad hangover.

Admittedly, Portola Pharmaceuticals was among last year's top performers, but its $ 2.5 billion market cap could still be too low if phase 3 trials of its factor Xa inhibitor betrixaban pan out.

Brian Feroldi (ACADIA Pharmaceuticals): Introducing a new drug to the market can be challenging, but the odds of success go up when there isn't any competition to worry about.

AbbVie, the pharmaceutical unit of Abbott Laboratories, sold $ 14.7 billion worth of bonds in the largest offering in the US corporate debt market in more than three years.

In 1996, Purdue Pharmaceuticals brought to market OxyContin, an «extended release» version of the opioid oxycodone.

The company has been working with companies in various segments of the market in Canada and the United States, and its goals include aligning with current product and consumer trends and offering top - quality food ingredients to the food, pharmaceuticals and nutraceutical industries.

They can look forward to market leaders in technology, covering the entire value chain in the core areas of food, pharmaceuticals, confectionery and baked goods, cosmetics, the retail trade, the automotive industry, milk and meat products, drinks and liquid food.

Alcohol Industry Bankrolls Fight Against Legal Pot in Battle of the Buzz: The fight against legalized pot is being heavily bankrolled by alcohol and pharmaceutical companies, terrified that they might lose market share...

Inc. takes the guesswork out of getting a product to market quickly and efficiently with its automated end - of - line packaging solutions for the food, beverage, tissue, paper, pharmaceutical and plastics markets.

The design and manufacture of advanced injection molding and assembly systems are a growing influence in the medical device, drug delivery, and primary pharmaceutical packaging markets.

Rousselot is the world leader in the production and marketing of gelatine and collagen peptides to the food and pharmaceutical industries.

With the development of smarter packaging, this specialist for secondary packaging in the pharma / pharmaceutical and healthcare industry meets the needs of increased digitalisation on the e-health market and the growing interest in interactive packaging solutions.

M&O Perry Industries is an ISO 9001:2000 registered manufacturer of filling equipment specifically designed for the pharmaceutical, biotech and animal health markets.

The pharmaceuticals market was a major driver of growth for German packaging machinery specialist Bosch Packaging Technology in 2013.

At Pharmapack Europe 2017, find hundreds of packaging solutions and drug delivery technology suppliers that serve the pharmaceutical, biopharmaceutical and veterinary markets.